Clinical Trial Articles & Analysis
-
First Home-Use Trial of the Bihormonal iLet With Dasiglucagon in a Pre-Filled, Commercial Ready, Pump Cartridge
This home-use clinical trial is being conducted by Dr. Steven Russell and his clinical research team at the Massachusetts General ...
-
Showcase
A Phase Ii Trial Of Onapristone In Combination With Fulvestrant For Patients With Er-Positive And Her2-Negative Metastatic Breast Cancer After Progression On Endocrine Therapy And Cdk 4/6 Inhibitors
Antiprogestins act as Progesterone Receptor (PgR) antagonists. Novel and promising class of drugs to overcome endocrine resistance associated with ESR1 mutations. SMILE STUDY is a multi-institutional phase II clinical trial to determine the efficacy of an antiprogestin, Onapristone +fulvestrantas second line therapy for patients with HR+/HER2- metastatic breast cancer (MBC). Hypothesis: The ...
-
SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox
NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...
-
German Federal Ministry of Education and Research („BMBF“) selects tiakis Biotech AG to develop Tiprelestat as a potential therapeutic for COVID-19.
tiakis Biotech AG (formerly Proteo Biotech AG) has announced that the German BMBF has selected the Company to conduct a clinical phase 1b/2 trial to develop its investigational medical product Tiprelestat as a potential therapeutic for COVID-19. The aim of the clinical trial is to assess Tiprelestat’s efficacy to attenuate severe disease progression of COVID-19. The Company expects the ...
-
Inspirata Joins Advarra’s New API Partner Program as an Inaugural Member
Cancer informatics provider Inspirata announced today that it has become a member of the Advarra Partner Program. As an inaugural API Gold partner, Inspirata will collaborate closely with Advarra’s engineering and support teams on ensuring out-of-the-box integrations between OnCore, an Advarra CTMS solution, and Trial Navigator, Inspirata’s fully automated, NLP-powered clinical trial ...
-
Clinical Trial Managers Need to Know These Skills for the Future
The Covid-19 epidemic has changed the world in many ways, and many clinical trials have been done to research more about it. According to the World Health Organization (WHO), 12,969 clinical trials were done in America in 2021. Even in pre-pandemic times, clinical trials have always been an ongoing process. Clinical trial managers work on cutting-edge studies and contribute to ...
By Brio Group
-
In the hands of ADAMO Robot
The clinical trials conducted by La Rioja’s healthcare service demonstrates the effectiveness of the only therapeutic massage robotic device that uses pressurized air to treat back pain. ...
By Adamo Robot
-
Showcase
POP Biotechnologies Vaccine Technology to Enter Phase III Clinical Studies as part of Eubiologics’ COVID-19 Vaccine Candidate, EuCorVac-19
POP Biotechnologies (POP BIO), a Buffalo, NY based biopharmaceutical startup, announces the approval of the plan for a phase 3 clinical study of EuCorVac-19, a COVID-19 vaccine candidate developed by South Korean partner EuBiologics (KOSDAQ: 206650, CEO, Dr. Baik YoungOk, Mr. Seukkeun Choi) from the Ministry of Food and Drug Safety in South Korea. EuCorVac-19, is a protein-based vaccine ...
-
NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”
NeuroScientific Biopharmaceuticals Director of Operations, Dr Alexandra Andrews provided an overview of the Company’s peptide-based drug for the treatment of neurodegenerative conditions and an update on the Company's progress towards clinical trials. To see video, please click ...
-
Analysis of Equipoise Shift in CLOTBUST-ER Has Been Published
Therapeutic Advances in Neurological Disorders has published “Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke”. This paper presents a case study of the CLOTBUST-ER trial, showing that the “increasing implementation of endovascular therapies across major academic stroke centers raises significant challenges for ...
-
How Great Clinical Trial Managers Stand Out From The Rest
Clinical Trial Manager roles are growing 32% faster than the national average. This job is undeniably rewarding but requires a high level of expertise and a knack for research. A clinical trial manager is responsible for many tasks, including overseeing everything from creating a valid test to its administration, recruitment, logistics, and follow-up. Hence, specific abilities ...
By Brio Group
-
Microbot Medical Commenced its First Step in the Anticipated Regulatory Process for its LIBERTY Robotic System
GLP Pre-Clinical Trial Commenced at a Leading Research Institute by Global Leaders in the Endovascular Space HINGHAM, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announces the commencement of its GLP Pre-Clinical Trial for the LIBERTY Robotic System at a world-class MedTech research laboratory. The study is being conducted by top Key Opinion Leaders (KOLs). ...
-
Clinical investigations
We performed 2 clinical trials in leading neurorehabilitation hospitals in Germany and Spain proving safety, feasibility and usability of the exoskeleton in a clinical setting, and showing significant improvements in clinical outcomes and benefits in rehabilitation. A Multicentric Clinical investigation in Institut Guttmann (Spain) and Heidelberg University Hospital (Germany), leading European ...
-
Qynapse to Sponsor and Present New Data on QyPredict at Clinical Trials on Alzheimer’s Disease Conference (CTAD 2021)
BOSTON, MA, November 4, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to sponsor the 14th Clinical Trials on Alzheimer’s Disease conference (CTAD) to be held from November 9-12, 2021, in Boston, MA. Qynapse will present new results on Qypredict®, ...
By Qynapse
-
Prolonged Analgesia From Bupisome And Bupigel Formulations: From Design And Fabrication To Improved Stability
Based on data from early animal studies, Probudur has indicated post-operative control for up to 96 hours, which is 24 hours longer than the leading product on the market. If we are able to demonstrate a successful Phase III clinical trial, we believe Probudur may represent the first long acting local anesthetic with an opioid sparing label. ...
-
Update on Biosceptre’s Phase 1 Clinical Trial for First-in-Class Oncology Vaccine BIL06v
Biosceptres’ Phase I clinical trial for peptide vaccine BIL06v has now completed enrolment of the first cohort of ten patients at the first dose, and all enrolled patients have received treatment. The trial was initiated in August and, subject to a scheduled safety review this week, it is expected that recruitment of the second cohort will begin before end of November. ...
-
Guide to Sample Size Re-Estimation in Clinical Trials
About the webinar We explore common challenges faced when designing and conducting clinical trials with sample size re-estimation (SSR). Common SSR methods are explored along with their pros and cons. We have also examined some real-world examples of these methods, while taking a look at what advantages their use can bring. Further below, you will find the webinar recording, slides and worked ...
By Statsol
-
CoNextions Medical Announces Initial Commercial Use of CoNextions TR Tendon Repair Device
A 17-year-old male patient with a severed extensor tendon of his thumb due to traumatic injury became the first outside of a clinical trial to undergo tendon repair with CoNextions Medical’s TR Tendon Repair device since the product’s recent approval in Chile, the first country to approve the device. “[The CoNextions TR] device is an excellent alternative [to suture],” ...
-
First Home-Use Trial of the iLet Bionic Pancreas System Using Pre-Filled Cartridges of Dasiglucagon Compatible With iLet Has Been Successfully Completed
Boston, MA and Copenhagen, Denmark - June 6,2019 - Beta Bionics, Inc. and Zealand Pharma A/S (NASDAQ: ZEAL) announced today that a home-use study of dasiglucagon in the iLet Bionic Pancreas System has been successfully completed. Beta Bionics and Zealand Pharma announce superior glycemic control in Phase 2 home-use clinical trial testing the iLet® bionic pancreas using ...
-
Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform
Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize clinical trial development, today announces that it has raised €2.5 million in a Series A2 financing round from Sanofi. The funds will be used to advance NOVA’s in silico clinical trial simulation platform, JINKO; to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you